CA2769420A1 - Proteases with modified pre-pro regions - Google Patents
Proteases with modified pre-pro regions Download PDFInfo
- Publication number
- CA2769420A1 CA2769420A1 CA2769420A CA2769420A CA2769420A1 CA 2769420 A1 CA2769420 A1 CA 2769420A1 CA 2769420 A CA2769420 A CA 2769420A CA 2769420 A CA2769420 A CA 2769420A CA 2769420 A1 CA2769420 A1 CA 2769420A1
- Authority
- CA
- Canada
- Prior art keywords
- protease
- polynucleotide
- seq
- amino acid
- host cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108091005804 Peptidases Proteins 0.000 title claims abstract description 374
- 239000004365 Protease Substances 0.000 title claims abstract description 359
- 102000035195 Peptidases Human genes 0.000 title abstract description 342
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 252
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 252
- 239000002157 polynucleotide Substances 0.000 claims abstract description 252
- 230000035772 mutation Effects 0.000 claims abstract description 158
- 238000004519 manufacturing process Methods 0.000 claims abstract description 92
- 238000000034 method Methods 0.000 claims abstract description 75
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 134
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 101
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 95
- 229920001184 polypeptide Polymers 0.000 claims description 92
- 229910052717 sulfur Inorganic materials 0.000 claims description 76
- 239000002243 precursor Substances 0.000 claims description 75
- 238000006467 substitution reaction Methods 0.000 claims description 61
- 108010022999 Serine Proteases Proteins 0.000 claims description 59
- 102000012479 Serine Proteases Human genes 0.000 claims description 59
- 238000012217 deletion Methods 0.000 claims description 58
- 230000037430 deletion Effects 0.000 claims description 58
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 57
- 229910052698 phosphorus Inorganic materials 0.000 claims description 56
- 229910052757 nitrogen Inorganic materials 0.000 claims description 52
- 229910052720 vanadium Inorganic materials 0.000 claims description 44
- 238000003780 insertion Methods 0.000 claims description 42
- 230000037431 insertion Effects 0.000 claims description 42
- 229910052727 yttrium Inorganic materials 0.000 claims description 40
- 244000063299 Bacillus subtilis Species 0.000 claims description 39
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 claims description 38
- 229910052739 hydrogen Inorganic materials 0.000 claims description 31
- 229910052721 tungsten Inorganic materials 0.000 claims description 24
- 239000013604 expression vector Substances 0.000 claims description 23
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 22
- 102220588447 Keratin, type I cytoskeletal 18_S49A_mutation Human genes 0.000 claims description 22
- 241000194108 Bacillus licheniformis Species 0.000 claims description 19
- 241000194103 Bacillus pumilus Species 0.000 claims description 16
- 229910052731 fluorine Inorganic materials 0.000 claims description 11
- 102220604132 Homeobox protein SIX3_K72D_mutation Human genes 0.000 claims description 9
- 229910052700 potassium Inorganic materials 0.000 claims description 8
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims description 7
- 241001328122 Bacillus clausii Species 0.000 claims description 5
- 241000193422 Bacillus lentus Species 0.000 claims description 5
- 241000193388 Bacillus thuringiensis Species 0.000 claims description 5
- 102220011740 rs386833408 Human genes 0.000 claims description 5
- 102220329691 rs892807467 Human genes 0.000 claims description 5
- 241000193752 Bacillus circulans Species 0.000 claims description 4
- 241000193749 Bacillus coagulans Species 0.000 claims description 4
- 241000194107 Bacillus megaterium Species 0.000 claims description 4
- 101100341057 Bacillus subtilis (strain 168) iolG gene Proteins 0.000 claims description 4
- 102220518628 Baculoviral IAP repeat-containing protein 6_T47E_mutation Human genes 0.000 claims description 4
- 102220519187 Casein kinase I isoform gamma-2_E88A_mutation Human genes 0.000 claims description 4
- 102220518326 Casein kinase I isoform gamma-2_K63A_mutation Human genes 0.000 claims description 4
- 102220526110 Dihydrofolate reductase_M20V_mutation Human genes 0.000 claims description 4
- 102220514894 Heterogeneous nuclear ribonucleoprotein F_K87R_mutation Human genes 0.000 claims description 4
- 101001115218 Homo sapiens Ubiquitin-40S ribosomal protein S27a Proteins 0.000 claims description 4
- 101150039072 INSA gene Proteins 0.000 claims description 4
- 102220588434 Keratin, type I cytoskeletal 18_S34E_mutation Human genes 0.000 claims description 4
- 102220567667 Matrilysin_P93N_mutation Human genes 0.000 claims description 4
- 102220518700 Mitochondrial import inner membrane translocase subunit TIM50_L11A_mutation Human genes 0.000 claims description 4
- 102220480981 Nicotinate phosphoribosyltransferase_K45G_mutation Human genes 0.000 claims description 4
- 102220635826 Probable C-mannosyltransferase DPY19L1_S26C_mutation Human genes 0.000 claims description 4
- 102220471793 Proteasome subunit alpha type-7_K39A_mutation Human genes 0.000 claims description 4
- 102220627932 Protein PIMREG_D58A_mutation Human genes 0.000 claims description 4
- 102220625480 RING finger protein 24_T50E_mutation Human genes 0.000 claims description 4
- 102220509220 Sphingosine 1-phosphate receptor 1_T80H_mutation Human genes 0.000 claims description 4
- 102100023341 Ubiquitin-40S ribosomal protein S27a Human genes 0.000 claims description 4
- 102220523693 Ubiquitin-related modifier 1_K55D_mutation Human genes 0.000 claims description 4
- 102220198533 rs1057520077 Human genes 0.000 claims description 4
- 102220199485 rs1057524453 Human genes 0.000 claims description 4
- 102200029723 rs11541017 Human genes 0.000 claims description 4
- 102200154383 rs121912761 Human genes 0.000 claims description 4
- 102200041867 rs121918148 Human genes 0.000 claims description 4
- 102200104802 rs13406336 Human genes 0.000 claims description 4
- 102220253361 rs1553234832 Human genes 0.000 claims description 4
- 102220277206 rs1553408288 Human genes 0.000 claims description 4
- 102220285635 rs1555280395 Human genes 0.000 claims description 4
- 102200051031 rs1870134 Human genes 0.000 claims description 4
- 102200052207 rs199469623 Human genes 0.000 claims description 4
- 102220005372 rs281860646 Human genes 0.000 claims description 4
- 102220005385 rs33921047 Human genes 0.000 claims description 4
- 102200082947 rs33954632 Human genes 0.000 claims description 4
- 102220005479 rs34182019 Human genes 0.000 claims description 4
- 102200092884 rs34933313 Human genes 0.000 claims description 4
- 102220032811 rs367543159 Human genes 0.000 claims description 4
- 102220074555 rs55858252 Human genes 0.000 claims description 4
- 102220040356 rs587778283 Human genes 0.000 claims description 4
- 102220177228 rs749006234 Human genes 0.000 claims description 4
- 102200072481 rs752745051 Human genes 0.000 claims description 4
- 102220082947 rs760368705 Human genes 0.000 claims description 4
- 102220065729 rs771965437 Human genes 0.000 claims description 4
- 102220083082 rs776859837 Human genes 0.000 claims description 4
- 102220324835 rs898303682 Human genes 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 241000006382 Bacillus halodurans Species 0.000 claims description 3
- 102220473604 Cytochrome b5_M51A_mutation Human genes 0.000 claims description 3
- 241000194109 Paenibacillus lautus Species 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 28
- 101710184263 Alkaline serine protease Proteins 0.000 claims 4
- 102220104204 rs879253774 Human genes 0.000 claims 2
- 241000149420 Bothrometopus brevis Species 0.000 claims 1
- 102220546222 Cell division cycle-associated protein 2_K66E_mutation Human genes 0.000 claims 1
- 102220604090 Homeobox protein SIX3_S52A_mutation Human genes 0.000 claims 1
- 101000755323 Homo sapiens 60S ribosomal protein L10a Proteins 0.000 claims 1
- 102220604136 Protein turtle homolog B_L10A_mutation Human genes 0.000 claims 1
- 102220354125 c.109_111delGAG Human genes 0.000 claims 1
- 102220022330 rs193922746 Human genes 0.000 claims 1
- 241000193830 Bacillus <bacterium> Species 0.000 abstract description 34
- 102000004190 Enzymes Human genes 0.000 abstract description 34
- 108090000790 Enzymes Proteins 0.000 abstract description 34
- 244000005700 microbiome Species 0.000 abstract description 13
- 238000012986 modification Methods 0.000 abstract description 13
- 230000004048 modification Effects 0.000 abstract description 13
- 235000019419 proteases Nutrition 0.000 description 278
- 210000004027 cell Anatomy 0.000 description 136
- 108090000623 proteins and genes Proteins 0.000 description 94
- 230000000694 effects Effects 0.000 description 64
- 102000004169 proteins and genes Human genes 0.000 description 60
- 235000018102 proteins Nutrition 0.000 description 58
- 108020004414 DNA Proteins 0.000 description 47
- 102000053602 DNA Human genes 0.000 description 46
- 235000001014 amino acid Nutrition 0.000 description 43
- 229940088598 enzyme Drugs 0.000 description 33
- 239000013612 plasmid Substances 0.000 description 33
- 150000007523 nucleic acids Chemical class 0.000 description 32
- 229940024606 amino acid Drugs 0.000 description 31
- 150000001413 amino acids Chemical class 0.000 description 31
- 239000012634 fragment Substances 0.000 description 26
- 239000013598 vector Substances 0.000 description 26
- 102000039446 nucleic acids Human genes 0.000 description 24
- 108020004707 nucleic acids Proteins 0.000 description 24
- 102220046722 rs61754447 Human genes 0.000 description 19
- 238000003556 assay Methods 0.000 description 17
- 108091028043 Nucleic acid sequence Proteins 0.000 description 16
- 102200057517 rs1800054 Human genes 0.000 description 15
- 102220467137 Activin receptor type-2B_K91A_mutation Human genes 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 14
- 125000003729 nucleotide group Chemical group 0.000 description 13
- 238000013518 transcription Methods 0.000 description 12
- 230000035897 transcription Effects 0.000 description 12
- 108010076504 Protein Sorting Signals Proteins 0.000 description 11
- 239000002773 nucleotide Substances 0.000 description 11
- 235000019833 protease Nutrition 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 8
- 108090000787 Subtilisin Proteins 0.000 description 8
- 101150009206 aprE gene Proteins 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 8
- LKDMKWNDBAVNQZ-WJNSRDFLSA-N 4-[[(2s)-1-[[(2s)-1-[(2s)-2-[[(2s)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-WJNSRDFLSA-N 0.000 description 7
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 7
- 230000003197 catalytic effect Effects 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 108010082371 succinyl-alanyl-alanyl-prolyl-phenylalanine-4-nitroanilide Proteins 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- 210000000349 chromosome Anatomy 0.000 description 6
- 238000010276 construction Methods 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 238000002703 mutagenesis Methods 0.000 description 6
- 231100000350 mutagenesis Toxicity 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 102220132395 rs1057515456 Human genes 0.000 description 6
- 108091005658 Basic proteases Proteins 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 241000579835 Merops Species 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000002797 proteolythic effect Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229910001868 water Inorganic materials 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
- 229960005091 chloramphenicol Drugs 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000193764 Brevibacillus brevis Species 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000006137 Luria-Bertani broth Substances 0.000 description 3
- RWCOTTLHDJWHRS-YUMQZZPRSA-N Pro-Pro Chemical group OC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RWCOTTLHDJWHRS-YUMQZZPRSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 102220596165 Uncharacterized protein C1orf131_S52A_mutation Human genes 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 102220353319 c.196A>G Human genes 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 101150089588 degU gene Proteins 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 3
- 235000019797 dipotassium phosphate Nutrition 0.000 description 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- -1 expression cassettes Proteins 0.000 description 3
- 230000037433 frameshift Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 3
- 108010077112 prolyl-proline Proteins 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000003362 replicative effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229920002477 rna polymer Polymers 0.000 description 3
- 102220099821 rs878853795 Human genes 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- VHJLVAABSRFDPM-UHFFFAOYSA-N 1,4-dithiothreitol Chemical compound SCC(O)C(O)CS VHJLVAABSRFDPM-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 101100286947 Escherichia coli (strain K12) insG gene Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 2
- 102220605052 Histone H4-like protein type G_S61A_mutation Human genes 0.000 description 2
- 101710172072 Kexin Proteins 0.000 description 2
- 239000007993 MOPS buffer Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 2
- 241000700124 Octodon degus Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- 101001072173 Streptomyces griseus Glutamyl endopeptidase 2 Proteins 0.000 description 2
- 101710135785 Subtilisin-like protease Proteins 0.000 description 2
- 108010056079 Subtilisins Proteins 0.000 description 2
- 102000005158 Subtilisins Human genes 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 241001659629 Virgibacillus Species 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- 239000013024 dilution buffer Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000003262 industrial enzyme Substances 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 101150077915 oppA gene Proteins 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 150000003355 serines Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- 108010078692 yeast proteinase B Proteins 0.000 description 2
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- 102220496137 5-hydroxytryptamine receptor 3B_K72N_mutation Human genes 0.000 description 1
- 241001147780 Alicyclobacillus Species 0.000 description 1
- 241001147782 Amphibacillus Species 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000555286 Aneurinibacillus Species 0.000 description 1
- 241001626813 Anoxybacillus Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 1
- NTQDELBZOMWXRS-IWGUZYHVSA-N Asp-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O NTQDELBZOMWXRS-IWGUZYHVSA-N 0.000 description 1
- 102000009422 Aspartic endopeptidases Human genes 0.000 description 1
- 108030004804 Aspartic endopeptidases Proteins 0.000 description 1
- 102100023053 Band 4.1-like protein 5 Human genes 0.000 description 1
- 101000851056 Bos taurus Elastin Proteins 0.000 description 1
- 241000555281 Brevibacillus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102220473676 DNA repair protein RAD50_Q70L_mutation Human genes 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 description 1
- 108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000488157 Escherichia sp. Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 108091060211 Expressed sequence tag Proteins 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 241000321606 Filobacillus Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 102220575544 Fucose mutarotase_Q46H_mutation Human genes 0.000 description 1
- 102220575557 Fucose mutarotase_S61P_mutation Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108090001126 Furin Proteins 0.000 description 1
- 102000004961 Furin Human genes 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 241001261512 Gracilibacillus Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000193004 Halobacillus Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101001049973 Homo sapiens Band 4.1-like protein 5 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 229910004616 Na2MoO4.2H2 O Inorganic materials 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108010064983 Ovomucin Proteins 0.000 description 1
- 241000179039 Paenibacillus Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- WOUIMBGNEUWXQG-VKHMYHEASA-N Ser-Gly Chemical compound OC[C@H](N)C(=O)NCC(O)=O WOUIMBGNEUWXQG-VKHMYHEASA-N 0.000 description 1
- WBAXJMCUFIXCNI-WDSKDSINSA-N Ser-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WBAXJMCUFIXCNI-WDSKDSINSA-N 0.000 description 1
- 108090000083 Serine Endopeptidases Proteins 0.000 description 1
- 102000003667 Serine Endopeptidases Human genes 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- 108700018667 Streptomyces subtilisin inhibitor Proteins 0.000 description 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
- BGRWYDHXPHLNKA-UHFFFAOYSA-N Tetraacetylethylenediamine Chemical compound CC(=O)N(C(C)=O)CCN(C(C)=O)C(C)=O BGRWYDHXPHLNKA-UHFFFAOYSA-N 0.000 description 1
- 241001291204 Thermobacillus Species 0.000 description 1
- 101000865057 Thermococcus litoralis DNA polymerase Proteins 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 239000007997 Tricine buffer Substances 0.000 description 1
- 241000321595 Ureibacillus Species 0.000 description 1
- HSRXSKHRSXRCFC-WDSKDSINSA-N Val-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(O)=O HSRXSKHRSXRCFC-WDSKDSINSA-N 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000003578 bacterial chromosome Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 102220363502 c.185A>T Human genes 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 101150085919 degQ gene Proteins 0.000 description 1
- 101150023726 degR gene Proteins 0.000 description 1
- 101150083941 degS gene Proteins 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 108010031145 eglin proteinase inhibitors Proteins 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 231100000221 frame shift mutation induction Toxicity 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002743 insertional mutagenesis Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- VBEGHXKAFSLLGE-UHFFFAOYSA-N n-phenylnitramide Chemical compound [O-][N+](=O)NC1=CC=CC=C1 VBEGHXKAFSLLGE-UHFFFAOYSA-N 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- 101150112117 nprE gene Proteins 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012268 protein inhibitor Substances 0.000 description 1
- 229940121649 protein inhibitor Drugs 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 102220094407 rs876658410 Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000003001 serine protease inhibitor Substances 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- FDEIWTXVNPKYDL-UHFFFAOYSA-N sodium molybdate dihydrate Chemical compound O.O.[Na+].[Na+].[O-][Mo]([O-])(=O)=O FDEIWTXVNPKYDL-UHFFFAOYSA-N 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- NCGJACBPALRHNG-UHFFFAOYSA-M sodium;2,4,6-trinitrobenzenesulfonate Chemical compound [Na+].[O-][N+](=O)C1=CC([N+]([O-])=O)=C(S([O-])(=O)=O)C([N+]([O-])=O)=C1 NCGJACBPALRHNG-UHFFFAOYSA-M 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23024709P | 2009-07-31 | 2009-07-31 | |
| US61/230,247 | 2009-07-31 | ||
| PCT/US2010/031283 WO2011014278A1 (en) | 2009-07-31 | 2010-04-15 | Proteases with modified pre-pro regions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2769420A1 true CA2769420A1 (en) | 2011-02-03 |
Family
ID=42342462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2769420A Abandoned CA2769420A1 (en) | 2009-07-31 | 2010-04-15 | Proteases with modified pre-pro regions |
Country Status (9)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140329309A1 (en) | 2011-12-09 | 2014-11-06 | Danisco Us Inc. | Ribosomal Promoters for Production in Microorganisms |
| GB201212932D0 (en) * | 2012-07-20 | 2012-09-05 | Dupont Nutrition Biosci Aps | Method |
| GB201212934D0 (en) * | 2012-07-20 | 2012-09-05 | Dupont Nutrition Biosci Aps | Method |
| DK3197472T3 (da) * | 2014-09-22 | 2021-10-18 | Tanea Medical Ab | Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri |
| WO2016134213A2 (en) | 2015-02-19 | 2016-08-25 | Danisco Us Inc | Enhanced protein expression |
| US10731144B2 (en) | 2015-06-17 | 2020-08-04 | Danisco Us Inc | Proteases with modified propeptide regions |
| JP7103948B2 (ja) | 2016-03-04 | 2022-07-20 | ダニスコ・ユーエス・インク | 微生物におけるタンパク質産生のための遺伝子操作されたリボソームプロモーター |
| DE102016204814A1 (de) | 2016-03-23 | 2017-09-28 | Henkel Ag & Co. Kgaa | Verbesserte Reinigungsleistung an Protein sensitiven Anschmutzungen |
| DE102016204815A1 (de) | 2016-03-23 | 2017-09-28 | Henkel Ag & Co. Kgaa | Proteasen mit verbesserte Enzymstabilität in Waschmittel |
| DE102016208463A1 (de) * | 2016-05-18 | 2017-11-23 | Henkel Ag & Co. Kgaa | Leistungsverbesserte Proteasen |
| WO2017210295A1 (en) * | 2016-05-31 | 2017-12-07 | Danisco Us Inc. | Protease variants and uses thereof |
| CN110846299B (zh) * | 2019-11-22 | 2021-09-24 | 江南大学 | 一种前导肽突变体及其在角蛋白酶生产中的应用 |
| WO2021230358A1 (ja) * | 2020-05-15 | 2021-11-18 | Jnc株式会社 | 抗ウイルス剤 |
| EP4525615A2 (en) | 2022-05-14 | 2025-03-26 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
| WO2025034713A2 (en) | 2023-08-09 | 2025-02-13 | Danisco Us Inc. | Compositions and methods for enhanced protein production in gram‑positive bacterial cells |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5310675A (en) * | 1983-06-24 | 1994-05-10 | Genencor, Inc. | Procaryotic carbonyl hydrolases |
| US5191063A (en) * | 1989-05-02 | 1993-03-02 | University Of Medicine And Dentistry Of New Jersey | Production of biologically active polypeptides by treatment with an exogenous peptide sequence |
| US6440717B1 (en) * | 1993-09-15 | 2002-08-27 | The Procter & Gamble Company | BPN′ variants having decreased adsorption and increased hydrolysis |
| US5431382A (en) * | 1994-01-19 | 1995-07-11 | Design Technology Corporation | Fabric panel feed system |
| US7101698B2 (en) * | 2002-06-26 | 2006-09-05 | Kao Corporation | Alkaline protease |
| CN101597601B (zh) * | 2002-06-26 | 2013-06-05 | 诺维信公司 | 具有改变的免疫原性的枯草杆菌酶和枯草杆菌酶变体 |
| JP4210548B2 (ja) * | 2002-06-26 | 2009-01-21 | 花王株式会社 | アルカリプロテアーゼ |
| US20080020440A1 (en) * | 2002-08-27 | 2008-01-24 | Daniel Tillett | Method of sequestering and/or purifying a polypeptide |
| US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| US7655242B2 (en) * | 2002-12-13 | 2010-02-02 | Case Western Reserve University | Defensin-inducing agents |
| US7490416B2 (en) * | 2004-01-26 | 2009-02-17 | Townsend Herbert E | Shoe with cushioning and speed enhancement midsole components and method for construction thereof |
| WO2008112258A2 (en) * | 2007-03-12 | 2008-09-18 | Danisco Us Inc. | Modified proteases |
| US20100297727A1 (en) * | 2007-06-06 | 2010-11-25 | Wolfgang Aehle | Methods for Improving Protein Performance |
| AR076312A1 (es) * | 2009-04-24 | 2011-06-01 | Danisco Us Inc | Proteasas con regiones pro modificadas |
-
2010
- 2010-04-15 EP EP10714541A patent/EP2459714A1/en not_active Withdrawn
- 2010-04-15 CA CA2769420A patent/CA2769420A1/en not_active Abandoned
- 2010-04-15 AR ARP100101264A patent/AR076311A1/es unknown
- 2010-04-15 JP JP2012522827A patent/JP5852568B2/ja not_active Expired - Fee Related
- 2010-04-15 US US12/761,253 patent/US20110171718A1/en not_active Abandoned
- 2010-04-15 WO PCT/US2010/031283 patent/WO2011014278A1/en active Application Filing
- 2010-04-15 BR BR112012002163A patent/BR112012002163A2/pt not_active IP Right Cessation
- 2010-04-15 IN IN312DEN2012 patent/IN2012DN00312A/en unknown
- 2010-04-15 CN CN201080043790.1A patent/CN102575242B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102575242B (zh) | 2015-03-25 |
| WO2011014278A1 (en) | 2011-02-03 |
| AR076311A1 (es) | 2011-06-01 |
| EP2459714A1 (en) | 2012-06-06 |
| BR112012002163A2 (pt) | 2015-11-03 |
| IN2012DN00312A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-05-08 |
| US20110171718A1 (en) | 2011-07-14 |
| CN102575242A (zh) | 2012-07-11 |
| JP2013500714A (ja) | 2013-01-10 |
| JP5852568B2 (ja) | 2016-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5852568B2 (ja) | 修飾されたプレ‐プロ領域を有するプロテアーゼ | |
| US10731144B2 (en) | Proteases with modified propeptide regions | |
| US9593320B2 (en) | Proteases with modified pro regions | |
| AU2008226792B2 (en) | Modified proteases | |
| HK1139982B (en) | Modified proteases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20150413 |
|
| FZDE | Dead |
Effective date: 20170906 |